Recombinant SARS-CoV-2/COVID-19 Omicron Mutant Nucleocapsid Protein

Product Information

Catalog Number	COV454
Product Name	Recombinant SARS-CoV-2/COVID-19 Omicron Mutant Nucleocapsid Protein
Alias	Recombinant SARS-CoV-2/COVID-19 Omicron Mutant N Protein, SARS-CoV-2/COVID-19 Omicron protein, Recombinant 2019-nCoV Spike N Omicron
Size	100μg,500μg
Molecular Weight	47.3KDa
Species	SARS-CoV-2
Expression Host	HEK293 Cells
Purity	≥ 95% as determined by SDS-PAGE
Buffer	Supplied in 0.01M PBS, pH7.4
Source	COV454 was expressed from E.coli The mutation sites are P13L, E31del, R32del, S33del, R203K, G204R
Background	The Omicron variant is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first reported to the World Health Organization (WHO) from South Africa on 24 November 2021. On 26 November 2021, the WHO designated it as a variant of concern and named it "Omicron", the fifteenth letter in the Greek alphabet.
Storage	Store the lyophilized powder at 4°C for one week and -20°C to -80°C for long term storage. Store the liquid form at -80°C. Avoid multiple freeze/thaw cycles.
Shipping Condition	Dry ice or ice packs.
Note	This product is used for research use only. Not for human or diagnostic use.

Cat#	Product Name	Species	Host	Applications	Size	Price